TABLE 1.
Protein | Product description |
---|---|
TGGT1_316250 | GRA45 |
TGGT1_204340 | GRA54 |
TGGT1_254470 | MYR1 |
TGGT1_319340 | GRA52 |
TGGT1_279100 | MAF1a |
TGGT1_251540 | GRA9 |
TGGT1_203600 | GRA50 |
TGGT1_304955 | Serine/threonine-specific protein phosphatase (PPM11C) |
TGGT1_315610 | Hypothetical protein |
TGGT1_203290 | GRA34 |
TGGT1_270320 | Protein phosphatase 2C domain-containing protein (PPM3C) |
TGGT1_258870 | Hypothetical protein |
TGGT1_311720 | Chaperonin protein BiP |
TGGT1_226240 | Putative bud site selection protein |
TGGT1_216770 | Hypothetical protein |
TGGT1_220950 | MAF1b |
TGGT1_270240 | MAG1 |
TGGT1_200360 | Hypothetical protein |
TGGT1_290700 | GRA25 |
TGGT1_258458 | Hypothetical protein |
TGGT1_262050 | Rhoptry kinase family protein ROP39 |
TGGT1_410360 | MAF1 copy |
TGGT1_247440 | GRA33 |
TGGT1_229480 | Putative calcium binding protein precursor |
TGGT1_208830 | GRA16 |
TGGT1_410370 | MAF1 copy |
The criteria used were a SAINT score (for the signal peptide) of >0.8 and not being a ribosomal protein (TGGT1_309820, TGGT1_207840, TGGT1_266070, TGGT1_248480). The shaded proteins have a predicted signal peptide based on SignalP analysis. Proteins are listed on the basis of their SAINT scores, total peptides, and the fold change in the number of peptides in experimental IPs over that for the controls (see Table S2 in the supplemental material).